Silo Pharma, Inc. (SILO)

Nasdaq · Pharmaceutical Preparations · Inc. NV

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 2 signals for Silo Pharma, Inc.. Most notable: 2026-07-13: Filed 8-K disclosing material agreement; 2026-08-19: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Material 8-K filing
    Filed 8-K disclosing material agreement
  4. Material 8-K filing
    Filed 8-K disclosing director or officer change
  5. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2025-12-15Weisblum EricdirectorP2,5000.42$1,050
2025-12-15Weisblum EricdirectorP2,5000.41$1,025
2025-11-21Weisblum EricdirectorP1,0000.37$370
2025-11-20Weisblum EricdirectorP1,0000.37$370
2025-11-19Weisblum EricdirectorP4,5000.41$1,845
2025-11-18Weisblum EricdirectorP7,5000.4$3,000
2025-05-27Weisblum EricdirectorP10,0000.43$4,300
2024-12-13Weisblum EricdirectorP2,5000.84$2,100
2024-11-22Weisblum EricdirectorP2,5000.9$2,250
2024-11-20Weisblum EricdirectorP2,5000.95$2,375

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings